MetaStat, Inc. (MTST)
OTCMKTS · Delayed Price · Currency is USD
0.0010
+0.0003 (42.86%)
At close: May 19, 2026
MetaStat Revenue
In the fiscal year ending February 28, 2018, MetaStat had annual revenue of $23.30K.
Revenue
23.30K
Revenue Growth
n/a
P/S Ratio
0.25
Revenue / Employee
3.88K
Employees
6
Market Cap
5.88K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Feb 28, 2018 | 23.30K | - | - |
| Feb 28, 2017 | - | - | - |
| Feb 29, 2016 | - | - | - |
| Feb 28, 2015 | - | - | - |
| Feb 28, 2014 | - | - | - |
| Feb 28, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 29, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hemagen Diagnostics | 4.04M |
| Statera Biopharma | 3.69M |
| MultiCell Technologies | 805.24K |
| Theralink Technologies | 635.45K |
| Bioasis Technologies | 199.01K |
| Therapeutic Solutions International | 85.32K |